-
Can Combination Therapy Improve Outcomes in PDE5i-Refractory Erectile Dysfunction? A Systematic Review of Low-Intensity Extracorporeal Shockwave Therapy
Volume 8 | Issue - 8
-
Influence of Storage Temperature on the Bond Performance of Universal Adhesives: A Narrative Review
Volume 8 | Issue - 8
-
Effects of direct acting antivirals(DAAs)on cryoglobulinemia in patients infected with hepatitis C virus
Volume 8 | Issue - 8
-
Effect of Education Sessions About Plastic Usage Hazards and Its Safe Disposal on Knowledge and Reported Practice of Female Employees at Port Said University: A Pre–Post Intervention Study
Volume 8 | Issue - 7
-
Soil Quality Under a Cocoa-Based Agroforestry System With Associated Indigenous Tree Species In The Department Of Divo (Cote d’Ivoire)
Volume 8 | Issue - 7
A PROSPECTIVE OBSERVATIONAL STUDY ON ASSESSMENT OF CLINICAL EFFICACY AND SAFETY OF RIFAXIMIN IN PATIENTS WITH NON- ALCOHOLIC FATTY LIVER DISEASE
Main Article Content
Abstract
Introduction: Non-alcoholic fatty liver disease (NAFLD) is a common liver condition characterized by macro-vesicular steatosis and absence of secondary causes like alcohol consumption or long-term medication use. NAFLD is a leading cause of liver-related morbidity and mortality, with a global prevalence of 30.05%.The prevalence of NAFLD is increasing in India due to changes in lifestyle and junk food availability, early detection and treatment are crucial to reduce NAFLD-related mortality.Treatment for NAFLD requires a multicentric approach, including drugs like GLP 1 agonists, metformin, vitamin E, and Rifaximin along with non-pharmacological strategies.
